Aureus launches AurPROFILER

Aureus Pharma, a France-based provider of knowledge management solutions for life science discovery, has launched the AurPROFILER, software that enables researchers to evaluate target, cell and drug profiles using bio-assays derived from the activity data found in Aureus Pharma's AurSCOPE Target Knowledge databases.

AurPROFILER has been designed to work in conjunction with the just released AurSCOPE Global Pharmacology Space and all of Aureus' drug target focused knowledge databases.

Compound profiling is routinely used by pharmaceutical researchers to evaluate the critical issues of drug target selectivity including off-target effects, polypharmacology and cytotoxicity. According to the Paris-based firm, with easily interpretable graphics, AurPROFILER provides valuable insights to help better manage these issues by rapidly providing in-silico profiles. AurPROFILER results facilitate better discovery team decision making, and reduce risk to streamline drug discovery projects, Aureus added.